{"id":102204,"date":"2023-09-18T07:44:47","date_gmt":"2023-09-18T07:44:47","guid":{"rendered":"https:\/\/dailytalks.org\/?p=102204"},"modified":"2023-09-18T07:44:47","modified_gmt":"2023-09-18T07:44:47","slug":"aptevo-therapeutics-inc-announces-closing-of-previously-announced-5-million-public-offering","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=102204","title":{"rendered":"Aptevo Therapeutics Inc. Announces Closing of Previously Announced $5 Million Public Offering"},"content":{"rendered":"<p>SEATTLE, WA \/ ACCESSWIRE \/ August 4, 2023 \/ Aptevo Therapeutics Inc. (NASDAQ:APVO) (&#8220;Aptevo&#8221; or the &#8220;Company&#8221;), a clinical stage biotechnology company focused on developing novel immuno-oncology therapeutics, today announced the closing of its previously announced public offering of 2,221,550 shares of common stock at a purchase price of $0.62 per share&#8230;<br \/><a href=\"https:\/\/www.accesswire.com\/viewarticle.aspx?id=772418&#038;lang=en\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SEATTLE, WA \/ ACCESSWIRE \/ August 4, 2023 \/ Aptevo Therapeutics Inc. (NASDAQ:APVO) (&#8220;Aptevo&#8221; or<\/p>\n","protected":false},"author":1,"featured_media":102205,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[],"class_list":["post-102204","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tech"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/102204-aptevo-therapeutics-inc-announces-closing-of-previously-announced-5-million-public-offering.PNG",400,400,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/102204-aptevo-therapeutics-inc-announces-closing-of-previously-announced-5-million-public-offering-150x150.png",150,150,true],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/102204-aptevo-therapeutics-inc-announces-closing-of-previously-announced-5-million-public-offering-300x300.png",300,300,true],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/102204-aptevo-therapeutics-inc-announces-closing-of-previously-announced-5-million-public-offering.PNG",400,400,false],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/102204-aptevo-therapeutics-inc-announces-closing-of-previously-announced-5-million-public-offering.PNG",400,400,false],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/102204-aptevo-therapeutics-inc-announces-closing-of-previously-announced-5-million-public-offering.PNG",400,400,false],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/102204-aptevo-therapeutics-inc-announces-closing-of-previously-announced-5-million-public-offering.PNG",400,400,false],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/102204-aptevo-therapeutics-inc-announces-closing-of-previously-announced-5-million-public-offering.PNG",400,400,false],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/102204-aptevo-therapeutics-inc-announces-closing-of-previously-announced-5-million-public-offering.PNG",400,400,false],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/09\/102204-aptevo-therapeutics-inc-announces-closing-of-previously-announced-5-million-public-offering.PNG",400,400,false]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=35\" rel=\"category\">Tech<\/a>","tag_info":"Tech","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/102204","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=102204"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/102204\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/102205"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=102204"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=102204"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=102204"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}